<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-12-07">December 7, 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><forename type="first">Claudia</forename><surname>Spies</surname></persName>
							<email>claudia.spies@charite.de</email>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alawi</forename><surname>Luetz</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Gunnar</forename><surname>Lachmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Renius</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Clarissa</forename><surname>Von Haefen</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Klaus-Dieter</forename><surname>Wernecke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Sostana GmbH</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marcus</forename><surname>Bahra</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of General, Abdominal and Transplantation Surgery</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Alexander</forename><surname>Schiemann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Marco</forename><surname>Paupers</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anesthesiology and Intensive Care Medicine</orgName>
								<orgName type="institution">Charité Mitte and Campus Virchow-Klinikum</orgName>
								<address>
									<addrLine>Campus</addrLine>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Charité -Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Meisel</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Institute of Medical Immunology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Virchow-Klinikum</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution">University of Pittsburgh</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">UNITED STATES</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">Influence of Granulocyte-Macrophage Colony-Stimulating Factor or Influenza Vaccination on HLA-DR, Infection and Delirium Days in Immunosuppressed Surgical Patients: Double Blind, Randomised Controlled Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-12-07">December 7, 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">0D5CA9EF605392EE07C9FBCF5D850616</idno>
					<idno type="DOI">10.1371/journal.pone.0144003</idno>
					<note type="submission">Received: July 11, 2015 Accepted: November 11, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Surgical patients are at high risk for developing infectious complications and postoperative delirium.</s><s>Prolonged infections and delirium result in worse outcome.</s><s>Granulocyte-macrophage colony-stimulating factor (GM-CSF) and influenza vaccination are known to increase HLA-DR on monocytes and improve immune reactivity.</s><s>This study aimed to investigate whether GM-CSF or vaccination reverses monocyte deactivation.</s><s>Secondary aims were whether it decreases infection and delirium days after esophageal or pancreatic resection over time.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>In this prospective, randomized, placebo-controlled, double-blind, double dummy trial setting on an interdisciplinary ICU of a university hospital 61 patients with immunosuppression (monocytic HLA-DR [mHLA-DR] &lt;10,000 monoclonal antibodies [mAb] per cell) on the first day after esophageal or pancreatic resection were treated with either GM-CSF (250 μg/m 2 / d), influenza vaccination (Mutagrip 0.5 ml/d) or placebo for a maximum of 3 consecutive days if mHLA-DR remained below 10,000 mAb per cell.</s><s>HLA-DR on monocytes was measured daily until day 5 after surgery.</s><s>Infections and delirium were followed up for 9 days PLOS ONE |</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Postoperative infections and delirium occur in up to 50% of high-risk patients undergoing high-risk surgery requiring intensive care unit (ICU) and prolonged hospital stay <ref type="bibr" target="#b0">[1]</ref><ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref>.</s><s>Surgical inflammatory stress can cause delirium and immune suppression <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>Postoperative immune suppression increases the risk for infections and delirium <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref>.</s></p><p><s>Immune suppression can be measured by a decreased level of human monocyte leukocyte antigen-DR receptor (mHLA-DR) expression on monocytes <ref type="bibr" target="#b11">[12]</ref>, a hallmark of monocyte deactivation associated with impaired innate and adaptive immune responses <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>.</s><s>Prolonged downregulation of mHLA-DR has been associated with worse outcomes such as infectious complications, severe sepsis and increased mortality in ICU patients <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref>.</s></p><p><s>Several studies have demonstrated that suppressed mHLA-DR could be restored by administration of vaccination or Granulocyte-Macrophage Colony-stimulating factor (GM-CSF) <ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref>.</s><s>Our research group found an increase in mHLA-DR after influenza vaccination in patients with untreated cancer of the upper aero-digestive tract <ref type="bibr" target="#b22">[23]</ref> and after preoperative vaccination <ref type="bibr" target="#b27">[28]</ref>.</s><s>Others found the normalization of the immunoregulatory index and the stimulation of the phagocytic function in the absence of essential influence on the level of HLA-DR + expression <ref type="bibr" target="#b28">[29]</ref>.</s><s>GM-CSF was known to restore reduced mHLA-DR in patients after cardiac surgery ex vivo <ref type="bibr" target="#b24">[25]</ref> as well as in vivo in patients with sepsis <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b26">27]</ref>.</s><s>However, whether GM-CSF or vaccination restore HLA-DR after major surgery in immunosuppressed patients is not known.</s></p><p><s>The primary aim of the study was to investigate the effect of postoperative treatment with GM-CSF or influenza vaccination on mHLA-DR expression.</s><s>Secondary endpoints were the number of infection and delirium days.</s></p><p><s>(www.charite.de).</s><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>One of the co-authors, Professor Klaus-Dieter Wernecke, is the owner of the commercial company Sostana GmbH Berlin.</s><s>However, there are no conflicts of interests in this case.</s><s>The funders of our study, 'Deutsche Forschungsgemeinschaft' and inneruniversitary grants, provided financial support in form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.</s><s>The specific roles of these authors are articulated in the 'author contributions' section.</s></p><p><s>Competing Interests: Deutsche Forschungsgemeinschaft DFG SP432-1, http://www.</s><s>dfg.de/.</s><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>Charité -Universitätsmedizin Berlin (www.charite.de).</s><s>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</s><s>See ICMJE Statistical analysis has been supervised by Professor Klaus-Dieter Wernecke, PhD, former head of the Institute of Medical Biometry at Charité -Universitätsmedizin Berlin and owner of Sostana GmbH.</s><s>The authors confirm that it does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Participants and Design</head><p><s>The first patient was enrolled on October 26, 2008.</s><s>However, due to technical issues including the payment process, the first acceptance of the corresponding ISRCTN application was delayed (December 05, 2008).</s><s>As a consequence 4 patients were included in the study before acceptance of the trial registration.</s><s>The authors confirm that all ongoing and related trials for this drug/intervention are registered.</s></p><p><s>Patients with immune suppression on day 1 after esophageal or pancreatic resection (pod1) were included in this prospective, randomized, placebo-controlled, double-blind, double dummy trial.</s><s>Immune suppression was defined as reduced mHLA-DR levels of less than 10,000 monoclonal antibodies (mAb) per cell <ref type="bibr" target="#b11">[12]</ref>.</s><s>Patient enrollment was from October 2008 to April 2011.</s><s>Patients were included if they were scheduled for elective esophageal or pancreatic surgery and had a mHLA-DR expression 10,000 antibodies per cell on pod1.</s><s>Exclusion criteria were acquired or congenital blood cell disease, leukemia, autoimmune diseases, allergies to GM-CSF or the influenza vaccine, chemotherapy or radiotherapy within the last 28 days, proven infection within the last 7 days, infection with HIV or hepatitis B or C, pharmacological immune suppression within the last 4 weeks, unstable angina pectoris, untreated arrhythmia, thromboembolic events, cachexia, thrombocytopenia ( 100,000 /μl), neutropenia ( 1,500 /μl), anemia (hemoglobin 8 g/dl), hyperbilirubinemia (&gt; 2 g/dl), creatinine &gt; 1.5 g/dl, aspartate aminotransferase (AST) or alanine aminotransferase (ALT) above 90 U/I, pregnancy or lactation, or participation in a German Drug Law (AMG) one month before and during the study.</s></p><p><s>A total of 319 patients scheduled for esophageal or pancreatic surgery were screened.</s><s>Of these, 235 did not fulfil inclusion criteria or refused to participate and 84 patients gave their written informed consent to participate.</s><s>Of the 84 patients who consented, 21 patients had to be excluded for the following reasons: 18 patients were not immune suppressed after surgery, 1 patient's operation was cancelled, in 1 patient pancreatic resection was not performed and 1 patient had abnormal preoperative laboratory values which were not available preoperatively and therefore delayed after surgery.</s><s>The remaining 63 patients were immune suppressed and were randomized according to the study protocol.</s><s>Two of the patients were excluded (major protocol violations) after randomization because one patient was inadvertently unblinded (placebo group) and one patient died of multiorgan failure after receiving study medication for 12.5 h (GM-CSF group, no causal relation to the study drug).</s><s>Three additional patients were randomized due to these two dropouts of the initially planned 60 patients.</s><s>Finally, 61 patients were included in data analysis (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>There were 23 minor protocol violations of inclusion criteria and 1 minor protocol violation regarding termination of the study medication.</s></p><p><s>The study was approved by the Ethics Committee of the Landesamt für Gesundheit und Soziales Berlin (LaGeSo), Germany (ref ZSEK15287/08) on September 01, 2008.</s><s>This clinical trial meets the requirements set out by the ICH-GCP, Declaration of Helsinki and the German Drug Law (AMG).</s><s>Written informed consent was obtained from patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Randomization and Treatment with Study Drugs</head><p><s>For blinding, consecutively numbered (randomization numbers) closed envelopes were used, which contained the assignment to the therapy.</s><s>In case of adverse reactions, severe deterioration of patient's state or other unforeseen events the patient and/or the physician had to be unblinded.</s><s>A list with the randomization numbers and instructions for treatment was available only to the study statistician and the local pharmacy.</s><s>The medications were prepared by an independent medically qualified person, who covered all medications for blinding.</s><s>This person was otherwise not involved in this study.</s></p><p><s>GM-CSF was administered intravenously (i.v.) and vaccination subcutaneously (s.c.).</s><s>To avoid bias, we applied a "double dummy" design: after inclusion patients were randomized in permutated blocks of six to receive either GM-CSF i.v. and 0.9% sodium chloride (NaCl) s.c., vaccination with the haemagglutinin antigens of the influenza virus s.c. and NaCl i.v. or placebo (NaCl i.v. and NaCl s.c.).</s><s>Starting on pod1, study drugs were administered as follows:</s></p><p><s>• GM-CSF group: 1 s.c.</s><s>syringe with 0.5 ml of 0.9% NaCl and 1 perfusor syringe with 24 ml of sargramostim (Leukine, Bayer Health Care, LLC.</s><s>Seattle, WA 98101, USA) 250 μg/m 2 body surface in 0.9% NaCl (1 ml/h i.v.)</s></p><p><s>• Vaccine group: 1 s.c.</s><s>syringe with 0.5 ml of influenza vaccine (Mutagrip 2009/2010, Sanofi Pasteur MSD GmbH, Leimen, Germany), 1 perfusor syringe with 24 ml of 0.9% NaCl (1 ml/ h i.v.)</s></p><p><s>• Placebo group: 1 s.c.</s><s>syringe with 0.5 ml of 0.9% NaCl, 1 perfusor syringe with 24 ml of 0.9% NaCl (1 ml/h i.v.)</s><s>All patients were treated with the study medication for 24 hours.</s><s>If mHLA-DR levels remained below 10,000 mAb per cell on day 2 and day 3 (pod2 and pod3) after surgery, administration of the study drugs was continued for a maximum of 72 hours (Fig <ref type="figure" target="#fig_1">2)</ref>.</s></p><p><s>Physicians in charge were unaware of group assignments and provided treatment without interference by the researchers.</s><s>All patients received standard perioperative treatment according to our standard operating procedures <ref type="bibr" target="#b29">[30]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow Cytometry and Measurement of Soluble Mediators</head><p><s>Blood samples were drawn daily starting on the day of surgery (dOs) until day 5 after surgery (pod5) for measurement of mHLA-DR expression, leukocytes, C-reactive protein (CRP), procalcitonin (PCT) and interleukin 6 (IL-6).</s></p><p><s>For detailed information see (S1 Methods).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical Outcome Parameters</head><p><s>During the follow-up period until day 9 after surgery (pod9), we measured infections according to CDC and ATS for pneumonia <ref type="bibr" target="#b30">[31,</ref><ref type="bibr" target="#b31">32]</ref>, incidence of delirium using the Delirium Detection Score (DDS, <ref type="bibr" target="#b5">[6]</ref>) with a DDS &gt; 3, hospital and ICU stay and disease severity using the following scores: Acute Physiology and Chronic Health Evaluation II (APACHE-II), Sequential Organ Failure Assessment (SOFA), Simplified Acute Physiology Score-II (SAPS-II) and Therapeutic Intervention Scoring System (TISS)-28.</s><s>All adverse and serious adverse events that occurred within 9 days after surgery were followed up until day 30 after surgery (Fig <ref type="figure" target="#fig_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p><s>Data were summarized using arithmetic mean ± standard deviation (SD), median [25%, 75% quartiles], or frequency [%], as appropriate.</s><s>Since this was an exploratory pilot study, sample size calculations were not performed.</s><s>Due to the distribution of the data, tests were performed using non-parametric methods.</s></p><p><s>For the primary endpoint mHLA-DR, infection duration, and delirium duration, differences among treatment groups on the first and second postoperative days (pod1 and pod2) were assessed using the Kruskal-Wallis test followed by pairwise comparisons using the Mann-Whitney test.</s><s>Differences within treatment groups between pod1 and pod2 (pre and post treatment) were assessed using the paired Wilcoxon test.</s><s>Basic patient characteristics and post intervention characteristics were evaluated for group differences using the Kruskal-Wallis test for continuous variates and the Fisher exact test for categorical variates.</s></p><p><s>All tests were two-tailed.</s><s>Statistical significance was declared at the 0.05 level.</s><s>Since this is an exploratory analysis, no adjustments for multiple testing were carried out.</s><s>All calculations were performed with IBM SPSS Statistics, Version 19, and SAS (Version 9.1) software.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Population and Study Groups</head><p><s>Basic patient characteristics did not differ between groups except for gender (p = 0.045) (Table <ref type="table" target="#tab_0">1</ref>).</s><s>In the GM-CSF group, study medication was given to all patients on pod1, to 1 patient on pod2, and to 3 patients on pod3.</s><s>In the vaccination group, study medication was given to all patients on pod1, to 20 patients on pod2 and to 15 patients on pod3.</s><s>In the placebo group, study medication was administered in all patients on pod1 and pod2 as well as in 17 patients on pod3.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Primary endpoint (mHLA-DR)</head><p><s>HLA-DR was increased compared to placebo (p &lt; 0.001) and influenza vaccination (p &lt; 0.001) on pod2 (Fig <ref type="table" target="#tab_2">3 and Table 2</ref>).</s><s>Differences between groups with respect to pre-post (pod1 -pod2) were seen for patients who received GM-CSF compared to those who received vaccination (p &lt; 0.001) and placebo (p &lt; 0.001; Table <ref type="table">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Secondary endpoints (infection and delirium, infection days and delirium days)</head><p><s>Fewer infection days were seen in the GM-CSF-treated patients (p &lt; 0.001) after surgery (Fig 4 <ref type="figure">;</ref> Table <ref type="table" target="#tab_2">3</ref>) compared to placebo.</s><s>During pod1 to pod9, infection was seen in 11 patients in the placebo group, in 9 patients in the vaccine group and in 8 patients in the GM-CSF group.</s><s>Pneumonia was the most frequent type of infection (n = 18) followed by sepsis (n = 6), wound infection (n = 5), urinary tract infection (n = 3) and other infections (n = 2).</s><s>These results did not differ between groups.</s></p><p><s>Delirium days were increased after influenza vaccination compared to the other groups (p = 0.003 and p = 0.007) after surgery (Fig 5 <ref type="figure">;</ref> Table <ref type="table" target="#tab_2">3</ref>).</s></p><p><s>For the period of pod1 to pod9, delirium rate did not differ significantly between groups (11 patients in the placebo group, 14 patients in the vaccine group and 12 patients in the GM-CSF group).</s></p><p><s>Leukocytes increased on pod2 after stimulation with GM-CSF and differed significantly from placebo (p = 0.003; <ref type="bibr">Fig 6)</ref>.</s><s>Temperature, CRP, PCT and IL-6 did not show any significant differences between the groups.</s></p><p><s>There were no significant differences in intra-and other postoperative parameters or in postoperative pain, postoperative nausea and vomiting or in ICU scores on admission Table <ref type="table">2</ref>. Monocytic HLA-DR (mHLA-DR) on day 1 (pod1) and day 2 (pod2) after surgery.</s><s>Paired Wilcoxon Test (pod1 versus pod2): Placebo: p = 0.0027; Vaccination: p = 0.013; GM-CSF: p &lt; 0.001; Overall (Kruskal-Wallis): pod1: p = 0.667; pod2: p &lt; 0.001; pod1 -pod2: p &lt; 0.001; IQR: Interquartile Range.</s><s>(Table <ref type="table" target="#tab_0">1</ref>).</s><s>In addition, maximum of SOFA and TISS 28 score as well as time on ventilator, ICU and hospital length of stay did not significantly differ between the groups (Table <ref type="table">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mean</head><p><s>No study drug-related serious adverse events, adverse drug-related reactions, unexpected adverse reactions or suspected unexpected severe adverse reactions were observed.</s><s>A detailed documentation of the safety data is given in (S1 Data).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The major finding of this study was that GM-CSF treatment after surgery in immune compromised patients increased mHLA-DR expression and decreased the number of infection days whereas influenza vaccination increased the number of delirium days after major surgery.</s><s>To the best of our knowledge, there have been no studies that investigated postoperative in vivo biomarker-guided administration of GM-CSF or vaccination in immune compromised surgical patients.</s><s>Several previous studies have demonstrated that GM-CSF can improve immune responses in immunosuppressed patients both ex vivo and in vivo.</s><s>Börgermann et al. showed that decreased mHLA-DR expression could be restored by GM-CSF ex vivo in patients undergoing cardiopulmonary bypass <ref type="bibr" target="#b24">[25]</ref>.</s><s>The same group demonstrated that GM-CSF also increases ex vivo endotoxin-induced monocyte cytokine release in immunosuppressed trauma patients <ref type="bibr" target="#b32">[33]</ref>.</s><s>In recent open-label and trials, we and others have shown that GM-CSF treatment can restore innate immune responses in adult patients with severe sepsis-associated immunosuppression and in children with multiple organ dysfunction syndrome <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b33">34]</ref>.</s><s>In accordance with previous studies, we observed an immediate increase of mHLA-DR to preoperative or even supernormal levels in patients with surgery-induced immunosuppression on the 1 st day after administration of GM-CSF.</s><s>This increase most likely relies on an induction of key molecules in the class II MHC pathway of monocytes <ref type="bibr" target="#b34">[35]</ref>.</s><s>However, mHLA-DR levels rapidly decreased when GM-CSF treatment was discontinued which is likely due to the short half-life of GM-CSF and replacement of circulating monocytes from the bone marrow pool.</s><s>Noteworthy, on the fifth day after surgery it decreased to levels comparable to the placebo group (mHLA-DR was over 10,000 mAb/cell but still depressed compared to preoperative levels).</s><s>GM-CSF treatment also increased the postoperative leukocyte counts while other markers of inflammation and infection such as temperature, CRP, PCT and IL-6 remained unaffected.</s><s>These data are in accordance with previous studies, which showed no effect of GM-CSF treatment on the infection parameters PCT and IL-6 in critically ill patients <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b33">34]</ref>.</s></p><p><s>Recent studies suggested that influenza vaccination could also increase suppressed mHLA-DR expression.</s><s>Haining et al. demonstrated increased mHLA-DR expression after influenza vaccination in children after hematopoietic stem cell transplantation <ref type="bibr" target="#b19">[20]</ref>.</s><s>We showed similar effects in patients with upper aerodigestive tract cancer <ref type="bibr" target="#b22">[23]</ref>.</s><s>In contrast, in the same study influenza vaccination failed to significantly prevent downregulation of mHLA-DR expression when the vaccine was administered pre-operatively <ref type="bibr" target="#b22">[23]</ref>.</s><s>Thus, in conjunction with the current study demonstrating no beneficial effect of post-operative influenza vaccination in immunosuppressed surgical patients, vaccination at least with influenza vaccine did not appear to be an effective immunostimulatory treatment approach either to prevent or to reverse surgery-induced immunosuppression.</s><s>After influenza vaccination, healthy volunteers showed a significant increase in the frequency of H1N1-specific IL-4+CD4+ T cells after vaccination.</s><s>However, healthy volunteers also showed an increase in IFN-γ+CD4+ T cells after vaccination despite the fact that no significant changes in HLA-DR-and CD86 expression from before to after vaccination were observed.</s><s>In addition, the cytokine profile after administration of vaccine showed that healthy controls had significantly greater levels of fractalkine, IFN-γ, MCP-3, interleukin 1β, interleukin 6, and MIP-1α <ref type="bibr" target="#b35">[36]</ref> i.e. they had a higher inflammatory cytokine load that might have influence on microglial activation and delirium days <ref type="bibr" target="#b36">[37]</ref>.</s></p><p><s>A recent meta-analysis of 12 randomized controlled trials including 2,380 patients by Bo et al. analyzed the effect of GM-CSF on clinical outcome parameters in sepsis.</s><s>GM-CSF was demonstrated to significantly increase the reversal rate of infections in sepsis patients <ref type="bibr" target="#b37">[38]</ref>.</s><s>In addition, Hall et al. found a significant reduction in secondary infectious complications in critically ill children under GM-CSF treatment <ref type="bibr" target="#b33">[34]</ref>.</s><s>However, until now no study has shown a decreased rate of nosocomial infections in surgical patients at risk after treatment with GM-CSF.</s><s>In our study, the infection days after surgery were significantly lower under GM-CSF treatment compared to placebo and vaccination group.</s><s>Nevertheless, despite the fact that the infection days were decreased up to day 9 after surgery, the total number of infections did not differ between groups.</s><s>These data suggest that GM-CSF treatment may mitigate the severity and duration but may not prevent the development of post-operative infectious episodes.</s><s>However, given that GM-CSF best protected patients from infections up to day 5 after surgery, short-term immunostimulatory treatment may not be sufficient.</s><s>In addition, mortality and comorbidity endpoints other than infection were not influenced by GM-CSF.</s><s>However, the current study was not powered to assess these endpoints.</s><s>Thus, additional studies are needed to determine the most effective duration of immunostimulatory treatment regimens and appropriate biomarker signatures indicative for sustained recovery of immune function and improved clinical outcome.</s></p><p><s>Another finding of our study is that vaccination increased the number of delirium days.</s><s>The number of delirium days is positively associated with increased 1-year mortality <ref type="bibr" target="#b38">[39,</ref><ref type="bibr" target="#b40">40]</ref>.</s><s>To the best of our knowledge, there is currently no study that describes a risk for delirium after influenza vaccination at all <ref type="bibr" target="#b41">[41]</ref><ref type="bibr" target="#b42">[42]</ref><ref type="bibr" target="#b43">[43]</ref> aside from one case report <ref type="bibr" target="#b44">[44]</ref>.</s><s>However, the pathogenesis of delirium is still not clearly understood.</s><s>Some studies suggest that systemic inflammation may affect cholinergic and immune system of major relevance in the development of delirium <ref type="bibr" target="#b45">[45]</ref><ref type="bibr" target="#b46">[46]</ref><ref type="bibr" target="#b47">[47]</ref>.</s><s>Hingorani et al. <ref type="bibr" target="#b48">[48]</ref> and Clapp et al. <ref type="bibr" target="#b49">[49]</ref> showed that vaccination leads to a systemic inflammatory response which is associated with endothelial dysfunction.</s><s>However, they used salmonella typhi vaccination.</s><s>Thus, we hypothesize that in our study influenza vaccination most likely induced a systemic inflammation which increased the risk of delirium perhaps due to disruption of the blood-brain barrier <ref type="bibr" target="#b36">[37,</ref><ref type="bibr" target="#b50">50,</ref><ref type="bibr" target="#b51">51]</ref>.</s><s>Influenza vaccination may have negative effects on delirium that might be related to unspecific inflammatory stimulation and should be investigated in further studies.</s></p><p><s>This study has several limitations.</s><s>First, study drugs were administered only for a maximum of 3 days.</s><s>The effect of longer duration of therapy is unclear.</s><s>Second, we observed small differences in univariate analyses for gender between the groups, but this was only descriptive because multivariate analysis is not considered appropriate in that setting and would not show any difference.</s><s>Third, the threshold level for mHLA-DR ( 10,000 mAb/cell) used to select patients with severe surgery-induced immunosuppression for immunostimulatory therapy in this study is unclear.</s><s>Previous studies have suggested using a mHLA-DR threshold between 5,000 and 10,000 mAb/cell as an indicator of severely impaired immune function in critical ill patients <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b23">24,</ref><ref type="bibr" target="#b52">52]</ref>.</s><s>However, it is currently unclear whether single cut-off values for mHLA-DR can be applied to identify best patients at risk with different entities of trauma-associated immunosuppression.</s><s>It was recently demonstrated that mHLA-DR levels of &lt; 20,000 mAb/cell were associated with the development of pneumonia in patients with severe stroke <ref type="bibr" target="#b53">[53]</ref>.</s><s>Thus, further studies are needed to determine outcome-relevant thresholds for biomarkers of immune competence in order to optimize the risk-benefit profile of immunostimulatory therapeutic approaches to overcome severe immunosuppression in critical illness.</s><s>Fourth, the use of influenza vaccine might have been insufficient to treat the HLA-DR response despite the fact that proinflammatory stimulation might have increased delirium.</s><s>A potential improvement would be to use a vaccine known to increase HLA-DR response such as vaccination against hepatitis B <ref type="bibr" target="#b54">[54]</ref>.</s><s>Finally, we observed patients for 9 days after surgery for infections.</s><s>Infections occurring after this time were not prospectively documented and could not be evaluated.</s><s>Furthermore, in this study we included patients after pancreatic and esophageal resection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>Postoperative application of GM-CSF significantly increased HLA-DR expression on monocytes and decreased the duration of infection after surgery in patients undergoing esophageal or pancreatic surgery.</s><s>Postoperative influenza vaccination had no influence on post-surgical immunosuppression but increased the number of delirium days.</s><s>Further studies are warranted to evaluate the benefit of immunostimulatory therapy with GM-CSF to improve clinical outcome.</s><s>The negative effects of influenza vaccination on cognition should be investigated as well.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Consort diagram.</s><s>dBs, day before surgery.</s><s>dOs, day of surgery.</s><s>pod, postoperative day.</s><s>doi:10.1371/journal.pone.0144003.g001</s></p></div></figDesc><graphic coords="4,200.01,78.01,307.28,346.90" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Flow diagram.</s><s>dBs, day before surgery.</s><s>dOs, day of surgery.</s><s>pod, postoperative day.</s><s>*Study drug treatment for a maximum of 3 consecutive days (pod1 -pod3) depending on mHLA-DR expression.</s><s>doi:10.1371/journal.pone.0144003.g002</s></p></div></figDesc><graphic coords="6,200.01,78.01,243.21,108.23" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Monocytic HLA-DR (mHLA-DR) over time.</s><s>Immediately before surgery (dOs) until day 5 after surgery (pod5) between groups.</s><s>doi:10.1371/journal.pone.0144003.g003</s></p></div></figDesc><graphic coords="7,200.01,78.01,240.09,160.84" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Number of infection days.</s><s>From day 1 (pod1, before intervention) until day 9 after surgery (pod9).</s><s>Between all three groups: p = 0.001.</s><s>Placebo vs. GM-CSF: p &lt; 0.001.</s><s>Placebo vs. vaccination: p = 0.068.</s><s>Vaccination vs. GM-CSF: p = 0.044.</s><s>doi:10.1371/journal.pone.0144003.g004</s></p></div></figDesc><graphic coords="8,200.01,78.01,262.38,210.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 5 .Fig 6 .</head><label>56</label><figDesc><div><p><s>Fig 5. Number of delirium days (DDS &gt; 3).</s><s>From day 1 (pod1, before intervention) until day 9 after surgery (pod9).</s><s>Between all three groups: p = 0.004.</s><s>Placebo vs. GM-CSF: p = 0.737.</s><s>Placebo vs. vaccination: p = 0.003.</s><s>Vaccination vs. GM-CSF: p = 0.007.</s><s>doi:10.1371/journal.pone.0144003.g005</s></p></div></figDesc><graphic coords="9,200.01,78.01,265.49,212.43" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Table 4 .</head><label>4</label><figDesc><div><p><s>Post-interventional course and outcome parameters.</s><s>Continuous quantities in median (25%-75% percentiles), frequencies with n; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; TISS, Therapeutic Intervention Scoring System; ICU, Intensive Care Unit.</s><s>Placebo (n = 20) Vaccine (n = 21) GM-CSF (n = 20) p-value (all groups) .1371/journal.pone.0144003.t004</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Basic patient characteristics and pre-interventional course.</s><s>Continuous quantities in median (25%-75% percentiles), frequencies with n (%); NRS, Numeric Rating Scale; dBs, day before surgery; pod1, day 1 after surgery; ASA, American Society of Anesthesiologists; AUDIT score, Alcohol Use Disorders Identification Test; PONV, postoperative nausea and vomiting; APACHE, Acute Physiology and Chronic Health Evaluation; SAPS, Simplified Acute Physiology Score; SOFA, Sequential Organ Failure Assessment; TISS, Therapeutic Intervention Scoring System; ICU, Intensive Care Unit.</s></p></div></figDesc><table><row><cell></cell><cell>Placebo (n = 20)</cell><cell>Vaccine (n = 21)</cell><cell>GM-CSF(n = 20)</cell><cell>p-value (all groups)</cell></row><row><cell>Age [years]</cell><cell>64 (55-74)</cell><cell>67 (62-72)</cell><cell>64 (53-70)</cell><cell>0.251</cell></row><row><cell>Gender male/female [n (%)]</cell><cell>11/9 (55/45)</cell><cell>15/6 (71/29)</cell><cell>18/2 (90/10)</cell><cell>0.045</cell></row><row><cell>Body Mass Index [kg/m 2 ]</cell><cell>25.5 (23.6-28.3)</cell><cell>24.5 (21.2-29.3)</cell><cell>26.9 (23.2-28.1)</cell><cell>0.917</cell></row><row><cell>Pancreatic/esophageal resection [n]</cell><cell>9/11</cell><cell>13/8</cell><cell>10/10</cell><cell>0.588</cell></row><row><cell>ASA score II/III [n]</cell><cell>12/8</cell><cell>9/12</cell><cell>9/11</cell><cell>0.532</cell></row><row><cell>smoker/nonsmoker/did never smoke [n]</cell><cell>8/5/7</cell><cell>6/10/5</cell><cell>5/9/6</cell><cell>0.601</cell></row><row><cell>AUDIT score</cell><cell>3 (0-6)</cell><cell>1 (0-7)</cell><cell>3 (0-5)</cell><cell>0.989</cell></row><row><cell>Metabolic equivalent (MET) &lt;4/4-10/&gt;10</cell><cell>1/17/2</cell><cell>2/18/1</cell><cell>0/19/1</cell><cell>0.853</cell></row><row><cell>NRS at rest dBs</cell><cell>0 (0-3)</cell><cell>0 (0-0)</cell><cell>0 (0-2)</cell><cell>0.356</cell></row><row><cell>NRS at rest pod1</cell><cell>3 (1-3)</cell><cell>3 (0-5)</cell><cell>3 (0-5)</cell><cell>0.525</cell></row><row><cell>NRS during movement pod1</cell><cell>5 (2-8)</cell><cell>4.5 (3-8)</cell><cell>6 (3-9)</cell><cell>0.351</cell></row><row><cell>Surgical time [min]</cell><cell>360 (304-440)</cell><cell>345 (275-430)</cell><cell>360 (345-430)</cell><cell>0.508</cell></row><row><cell>Blood loss [ml]</cell><cell>625 (338-1000)</cell><cell>600 (400-800)</cell><cell>700 (500-1100)</cell><cell>0.616</cell></row><row><cell>Blood glucose [mg/dl]</cell><cell>131 (120-139)</cell><cell>140 (128-164)</cell><cell>137 (122-147)</cell><cell>0.150</cell></row><row><cell>Blood lactate [mmol/l] (max.)</cell><cell>1.44 (1.10-1.87)</cell><cell>1.67 (1.06-1.95)</cell><cell>1.72 (1.24-2.64)</cell><cell>0.549</cell></row><row><cell>Systolic blood pressure [mmHg]</cell><cell>115 (112-120)</cell><cell>122 (110-130)</cell><cell>115 (112-125)</cell><cell>0.446</cell></row><row><cell>PONV</cell><cell>2 (1.00-3.00)</cell><cell>1 (0.00-2.00)</cell><cell>1 (1.00-2.00)</cell><cell>0.510</cell></row><row><cell>APACHE II scoreon admission to ICU</cell><cell>16 (11-18)</cell><cell>14 (7-18)</cell><cell>12 (11-16)</cell><cell>0.411</cell></row><row><cell>SAPS II scoreon admission to ICU</cell><cell>27 (21-42)</cell><cell>25 (17-30)</cell><cell>28 (22-33)</cell><cell>0.829</cell></row><row><cell>SOFA scoreon admission to ICU</cell><cell>2.5 (0.3-5.0)</cell><cell>0.0 (0.0-3.0)</cell><cell>1.0 (0.0-4.8)</cell><cell>0.185</cell></row><row><cell>TISS 28 score on admission to ICU</cell><cell>32.5 (28.0-38.5)</cell><cell>32.0 (25.0-37.0)</cell><cell>32.0 (29.0-35.5)</cell><cell>0.876</cell></row></table><note><p><s>doi:10.1371/journal.pone.0144003.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 3 .</head><label>3</label><figDesc><div><p><s>Infection and delirium days (DDS &gt; 3).</s><s>Overall (Kruskal-Wallis): Infection days: p = 0.001; Delirium days (DDS &gt; 3): p = 0.004; IQR: Interquartile Range.</s></p></div></figDesc><table><row><cell></cell><cell>Mean</cell><cell>Standard deviation</cell><cell>Median</cell><cell>IQR</cell><cell cols="3">p-values (Mann-Whitney)</cell></row><row><cell>Duration of Infection (days)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1 vs. 2</cell><cell>1 vs. 3</cell><cell>2 vs. 3</cell></row><row><cell>1: Placebo</cell><cell>1.35</cell><cell>1.982</cell><cell>0.00</cell><cell>3</cell><cell>0.068</cell><cell>&lt; 0.001</cell></row><row><cell>2: Vaccination</cell><cell>1.05</cell><cell>1.883</cell><cell>0.00</cell><cell>2</cell><cell></cell><cell></cell><cell>0.044</cell></row><row><cell>3: GM-CSF</cell><cell>0.74</cell><cell>1.807</cell><cell>0.00</cell><cell>0</cell><cell></cell><cell></cell></row><row><cell>Duration of Delirium (days)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>1 vs. 2</cell><cell>1 vs. 3</cell><cell>2 vs. 3</cell></row><row><cell>1: Placebo</cell><cell>0.6222</cell><cell>1.1194</cell><cell>0.00</cell><cell>1</cell><cell>0.003</cell><cell>0.737</cell></row><row><cell>2: Vaccination</cell><cell>0.9788</cell><cell>1.3247</cell><cell>0.00</cell><cell>2</cell><cell></cell><cell></cell><cell>0.007</cell></row><row><cell>3: GM-CSF</cell><cell>0.5556</cell><cell>0.8471</cell><cell>0.00</cell><cell>1</cell><cell></cell><cell></cell></row></table><note><p><s>doi:10.1371/journal.pone.0144003.t003</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0144003 December 7, 2015</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We are very grateful to Kathrin Scholtz for monitoring this study, to the sub investigators Lilit Sargsyan, Ulrike Wittkowski for their help to temporarily conduct this clinical trial, Johannes Kurth, Anja-Vanessa Philippeit, Dominik Stöber, Fatima Yürek, Julia Schäfer, Carolyn Geipel, Kay Dittrich, Sara Schillo, Siven Relindise and Annegret Winkler for data collection and help with the data base.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">Mortality attributable to hospital-acquired infections among surgical patients. Infection control and hospital epidemiology: the official journal of the Society of Hospital Epidemiologists of America</title>
		<author>
			<persName><forename type="first">C</forename><surname>Geffers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gastmeier</surname></persName>
		</author>
		<idno type="DOI">10.1086/592410</idno>
		<idno type="PMID">19014317</idno>
		<imprint>
			<date type="published" when="2008">2008. 2008/11/19</date>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1167" to="1170" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Angus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Linde-Zwirble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lidicker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Clermont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Carcillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Pinsky</surname></persName>
		</author>
		<idno type="PMID">11445675</idno>
	</analytic>
	<monogr>
		<title level="j">Critical care medicine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1303" to="1310" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Preoperative risk assessment for delirium after noncardiac surgery: a systematic review</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dasgupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Dumbrell</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1532-5415.2006.00893.x</idno>
		<idno type="PMID">17038078</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Geriatrics Society</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1578" to="1589" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Comparison of three scores to screen for delirium in the recovery room</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Radtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Luetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seeling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heinz</surname></persName>
		</author>
		<idno type="DOI">10.1093/bja/aen193</idno>
		<idno type="PMID">18603528</idno>
	</analytic>
	<monogr>
		<title level="j">British journal of anaesthesia</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="338" to="343" />
			<date type="published" when="2008-07-08">2008. 2008/07/08</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A comparison of three scores to screen for delirium on the surgical ward</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Radtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Franck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schust</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Boehme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pascher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Bail</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00268-009-0376-9</idno>
		<idno type="PMID">20066416</idno>
	</analytic>
	<monogr>
		<title level="j">World journal of surgery</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="487" to="494" />
			<date type="published" when="2010-01-13">2010. 2010/01/ 13</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Different assessment tools for intensive care unit delirium: which score to use?</title>
		<author>
			<persName><forename type="first">A</forename><surname>Luetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heymann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Radtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chenitir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Neuhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nachtigall</surname></persName>
		</author>
		<idno type="DOI">10.1097/CCM.0b013e3181cabb42</idno>
		<idno type="PMID">20029345</idno>
	</analytic>
	<monogr>
		<title level="j">Critical care medicine</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="409" to="418" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Nosocomial infection, indices of intrinsic infection risk, and in-hospital mortality in general surgery. The Journal of hospital infection</title>
		<author>
			<persName><forename type="first">M</forename><surname>Delgado-Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gomez-Ortega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Llorca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lecuona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Dierssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sillero-Arenas</surname></persName>
		</author>
		<idno type="PMID">10204122</idno>
		<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="203" to="211" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Distinct mechanisms of immunosuppression as a consequence of major surgery</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hensler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heeg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Heidecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Bartels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Barthlen</surname></persName>
		</author>
		<idno type="PMID">9169765</idno>
		<idno type="PMCID">PMC175317</idno>
	</analytic>
	<monogr>
		<title level="j">Infection and immunity</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2283" to="2291" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Changes in major histocompatibility complex class II expression in monocytes and T cells of patients developing infection after surgery. The British journal of surgery</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Wakefield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Foulds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Monson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Guillou</surname></persName>
		</author>
		<idno type="PMID">8443652</idno>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="205" to="209" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<monogr>
		<title level="m" type="main">Intensive Care Infection Score-A new approach to distinguish between infectious and noninfectious processes in intensive care and medicosurgical patients. The Journal of international medical research</title>
		<author>
			<persName><forename type="first">K</forename><surname>Weimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wernecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Vicherek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nachtigall</surname></persName>
		</author>
		<idno type="DOI">10.1177/0300060514557711</idno>
		<idno type="PMID">25850686</idno>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Altered cell-mediated immunity and increased postoperative infection rate in long-term alcoholic patients</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Von Dossow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Eggers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Jetschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>El-Hilali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Egert</surname></persName>
		</author>
		<idno type="PMID">15114205</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1088" to="1100" />
			<date type="published" when="2004-04-29">2004. 2004/04/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Monitoring temporary immunodepression by flow cytometric measurement of monocytic HLA-DR expression: a multicenter standardized study</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Docke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hoflich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rottgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kiefer</surname></persName>
		</author>
		<idno type="DOI">10.1373/clinchem.2005.052639</idno>
		<idno type="PMID">16214828</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical chemistry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2341" to="2347" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Delayed treatment of delirium increases mortality rate in intensive care unit patients</title>
		<author>
			<persName><forename type="first">A</forename><surname>Heymann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Radtke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schiemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lutz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Macguill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wernecke</surname></persName>
		</author>
		<idno type="PMID">21309472</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of international medical research</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1584" to="1595" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Myocardial ischemia and cytokine response are associated with subsequent onset of infections after noncardiac surgery</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kern</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sepold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lang</surname></persName>
		</author>
		<idno type="PMID">12088935</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesia and analgesia</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="9" to="18" />
			<date type="published" when="2002-06-29">2002. 2002/06/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Monocyte function before and after surgical trauma. Digestive surgery</title>
		<author>
			<persName><forename type="first">W</forename><surname>Haupt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Riese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mehler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hohenberger</surname></persName>
		</author>
		<idno type="PMID">9845570</idno>
		<imprint>
			<date type="published" when="1998">1998</date>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="102" to="104" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Changes of monocyte human leukocyte antigen-DR expression as a reliable predictor of mortality in severe sepsis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ou-Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc10457</idno>
		<idno type="PMID">21933399</idno>
		<idno type="PMCID">PMC3334765</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">R220</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main">Monocytic HLA-DR expression in intensive care patients: interest for prognosis and secondary infection prediction. Critical care medicine</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Lukaszewicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Grienay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Resche-Rigon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pirracchio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Faivre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Boval</surname></persName>
		</author>
		<idno type="DOI">10.1097/CCM.0b013e3181ab858a</idno>
		<idno type="PMID">19707128</idno>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2746" to="2752" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Low monocyte human leukocyte antigen-DR is independently associated with nosocomial infections after septic shock. Intensive care medicine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Landelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lepape</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Voirin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tognet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Venet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bohe</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00134-010-1962-x</idno>
		<idno type="PMID">20652682</idno>
		<imprint>
			<date type="published" when="2010">2010</date>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="1859" to="1866" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Functional analysis of monocyte subsets in surgical sepsis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Schinkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sendtner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zimmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Faist</surname></persName>
		</author>
		<idno type="PMID">9603073</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of trauma</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="743" to="748" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>discussion 8-9</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Measuring T cell immunity to influenza vaccination in children after haemopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">N</forename><surname>Haining</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Seth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Callaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Wucherpfennig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Nadler</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2141.2004.05204.x</idno>
		<idno type="PMID">15491293</idno>
	</analytic>
	<monogr>
		<title level="j">British journal of haematology</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="322" to="325" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses</title>
		<author>
			<persName><forename type="first">V</forename><surname>Blazevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Trubey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Shearer</surname></persName>
		</author>
		<idno type="PMID">11053627</idno>
	</analytic>
	<monogr>
		<title level="j">Human immunology</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="845" to="849" />
			<date type="published" when="2000">2000. 2000/10/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Infectious Diseases HIVVTN. HIV type 1 vaccine-induced T cell memory and cytotoxic T lymphocyte responses in HIV type 1-uninfected volunteers</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Gorse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Belshe</surname></persName>
		</author>
		<idno type="DOI">10.1089/088922201316912781</idno>
		<idno type="PMID">11522187</idno>
	</analytic>
	<monogr>
		<title level="j">AIDS research and human retroviruses</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1175" to="1189" />
			<date type="published" when="2001">2001</date>
		</imprint>
		<respStmt>
			<orgName>National Institute of A</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">Influence of vaccination and surgery on HLA-DR expression in patients with upper aerodigestive tract cancer. The Journal of international medical research</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Breuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meyerhoefer</surname></persName>
		</author>
		<idno type="PMID">18380940</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="296" to="307" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Granulocyte-macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. American journal of respiratory and critical care medicine</title>
		<author>
			<persName><forename type="first">C</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Schefold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pschowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Baumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hetzger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gregor</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.200903-0363OC</idno>
		<idno type="PMID">19590022</idno>
		<imprint>
			<date type="published" when="2009-07-11">2009. 2009/07/11</date>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="640" to="648" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<monogr>
		<title level="m" type="main">Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass. The Thoracic and cardiovascular surgeon</title>
		<author>
			<persName><forename type="first">J</forename><surname>Borgermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Friedrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scheubel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Kuss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lendemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Silber</surname></persName>
		</author>
		<idno type="PMID">17285470</idno>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="24" to="31" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Reversal of immunoparalysis by recombinant human granulocyte-macrophage colony-stimulating factor in patients with severe sepsis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Nierhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Montag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Timmler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Frings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gutensohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Jung</surname></persName>
		</author>
		<idno type="PMID">12595977</idno>
	</analytic>
	<monogr>
		<title level="j">Intensive care medicine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="646" to="651" />
			<date type="published" when="2003-02-22">2003. 2003/02/22</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">A randomized trial of granulocyte-macrophage colony-stimulating factor in neonates with sepsis and neutropenia</title>
		<author>
			<persName><forename type="first">K</forename><surname>Bilgin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yaramis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Haspolat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Tas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gunbey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Derman</surname></persName>
		</author>
		<idno type="PMID">11134431</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="36" to="41" />
			<date type="published" when="2001-01-03">2001. 2001/01/03</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Influence of preoperative vaccination on monocytic HLA-DR expression and postoperative infection rate of patients with upper aerodigestive tract cancer: A randomised trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Goldmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Renius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kleinwaechter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Von Haefen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Wernecke</surname></persName>
		</author>
		<idno type="DOI">10.1097/EJA.0000000000000171</idno>
		<idno type="PMID">25564783</idno>
	</analytic>
	<monogr>
		<title level="j">European journal of anaesthesiology</title>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Characteristics of the immune status in specific and nonspecific prophylaxis of influenza in elderly persons</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Semenenko</surname></persName>
		</author>
		<author>
			<persName><surname>Ep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Gotvianskaia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Gaidarenko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Polezhaeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Evseeva</surname></persName>
		</author>
		<idno type="PMID">16438370</idno>
	</analytic>
	<monogr>
		<title level="j">Zhurnal mikrobiologii, epidemiologii, i immunobiologii</title>
		<imprint>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="24" to="28" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<monogr>
		<title level="m" type="main">SOPs in Intensivmedizin und Notfallmedizin: Alle relevanten Standards und Techniken für die Klinik</title>
		<author>
			<persName><forename type="first">C</forename><surname>Spies</surname></persName>
		</author>
		<author>
			<persName><surname>Kw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kastrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Melzer-Gartzke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zielke</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<publisher>Georg Thieme Verlag</publisher>
			<pubPlace>Stuttgart</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Horan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Gaynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Martone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Jarvis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Emori</surname></persName>
		</author>
		<idno type="PMID">1332552</idno>
	</analytic>
	<monogr>
		<title level="j">American journal of infection control</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="271" to="274" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<monogr>
		<title level="m" type="main">Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American journal of respiratory and critical care medicine</title>
		<author>
			<persName><forename type="first">American</forename><surname>Thoracic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
		<idno type="PMID">15699079</idno>
		<imprint>
			<date type="published" when="2005">2005</date>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="page" from="388" to="416" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<monogr>
		<title level="m" type="main">Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Inflammation research: official journal of the European Histamine Research Society</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lendemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kreuzfelder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Waydhas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">U</forename><surname>Schade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Flohe</surname></persName>
		</author>
		<idno type="PMID">17334669</idno>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="38" to="44" />
		</imprint>
	</monogr>
	<note>et al</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Knatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vetterly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tomarello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wewers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Volk</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00134-010-2088-x</idno>
		<idno type="PMID">21153402</idno>
	</analytic>
	<monogr>
		<title level="j">Intensive care medicine</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="525" to="532" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Regulation of the class II MHC pathway in primary human monocytes by granulocyte-macrophage colony-stimulating factor</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Hornell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Beresford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bushey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Boss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Mellins</surname></persName>
		</author>
		<idno type="PMID">12928384</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of immunology</title>
		<imprint>
			<biblScope unit="volume">171</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="2374" to="2383" />
			<date type="published" when="2003-08-21">2003. 2003/08/21</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination. The Journal of infectious diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Egli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Humar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Widmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Lisboa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Santer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mueller</surname></persName>
		</author>
		<idno type="DOI">10.1093/infdis/jiv015</idno>
		<idno type="PMID">25589334</idno>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">212</biblScope>
			<biblScope unit="page" from="137" to="146" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<monogr>
		<title level="m" type="main">Pathophysiology of acute brain dysfunction: what&apos;s the cause of all this confusion? Current opinion in critical care</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Hughes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Pandharipande</surname></persName>
		</author>
		<idno type="DOI">10.1097/MCC.0b013e328357effa</idno>
		<idno type="PMID">22941208</idno>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="518" to="526" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Granulocyte-colony stimulating factor (G-CSF) and granulocytemacrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Deng</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc10031</idno>
		<idno type="PMID">21310070</idno>
		<idno type="PMCID">PMC3221991</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Care</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">R58</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">Days of delirium are associated with 1-year mortality in an older intensive care unit population. American journal of respiratory and critical care medicine</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Pisani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Kasl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Araujo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Ness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename></persName>
		</author>
		<idno type="DOI">10.1164/rccm.200904-0537OC</idno>
		<idno type="PMID">19745202</idno>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="1092" to="1097" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">PubMed Central</title>
		<idno type="PMCID">PMC2784414</idno>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main">Rapidly reversible, sedation-related delirium versus persistent delirium in the intensive care unit. American journal of respiratory and critical care medicine</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Poston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pohlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Kress</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201310-1815OC</idno>
		<idno type="PMID">24423152</idno>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="658" to="665" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Noss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Blatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Biedenbender</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Decker</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.vaccine.2012.11.074</idno>
		<idno type="PMID">23228813</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="770" to="776" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A prospective, randomized, open-label trial comparing the safety and efficacy of trivalent live attenuated and inactivated influenza vaccines in adults 60 years of age and older</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Forrest</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Steele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hiemstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rappaport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Ambrose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Gruber</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.vaccine.2011.03.029</idno>
		<idno type="PMID">21440036</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">20</biblScope>
			<biblScope unit="page" from="3633" to="3639" />
			<date type="published" when="2011-03-29">2011. 2011/03/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring</title>
		<author>
			<persName><forename type="first">C</forename><surname>Vellozzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Burwen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dobardzic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Walton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Haber</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.vaccine.2009.01.125</idno>
		<idno type="PMID">19356614</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="issue">15</biblScope>
			<biblScope unit="page" from="2114" to="2120" />
			<date type="published" when="2009-04-10">2009. 2009/04/10</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Delirium following influenza vaccination. The American journal of psychiatry</title>
		<author>
			<persName><forename type="first">N</forename><surname>Boutros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Keck</surname></persName>
		</author>
		<idno type="PMID">8238653</idno>
		<imprint>
			<date type="published" when="1993">1993</date>
			<biblScope unit="volume">150</biblScope>
			<biblScope unit="page">1899</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">The cholinergic system and inflammation: common pathways in delirium pathophysiology</title>
		<author>
			<persName><forename type="first">J</forename><surname>Cerejeira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Nogueira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Luis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vaz-Serra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Mukaetova-Ladinska</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1532-5415.2011.03883.x</idno>
		<idno type="PMID">22316182</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the American Geriatrics Society</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="669" to="675" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<monogr>
		<title level="m" type="main">Pathophysiology of postoperative delirium: systemic inflammation as a response to surgical trauma causes diffuse microcirculatory impairment. Medical hypotheses</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hala</surname></persName>
		</author>
		<idno type="PMID">16979300</idno>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="194" to="196" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Systemic inflammation induces acute working memory deficits in the primed brain: relevance for delirium</title>
		<author>
			<persName><forename type="first">C</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Sanderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Barkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Deacon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Rawlins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Bannerman</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.neurobiolaging.2010.04.002</idno>
		<idno type="PMID">20471138</idno>
		<idno type="PMCID">PMC3200140</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiology of aging</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">e3</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Acute systemic inflammation impairs endothelium-dependent dilatation in humans</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Kharbanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Mullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bhagat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Taylor</surname></persName>
		</author>
		<idno type="PMID">10961963</idno>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="994" to="999" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Clapp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hingorani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Kharbanda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mohamed-Ali</forename></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Stephens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Vallance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.cardiores.2004.06.020</idno>
		<idno type="PMID">15364625</idno>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular research</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="172" to="178" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Systemic infection and delirium: when cytokines and acetylcholine collide</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Van Gool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Van De Beek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Eikelenboom</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(09)61158-2</idno>
		<idno type="PMID">20189029</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">375</biblScope>
			<biblScope unit="issue">9716</biblScope>
			<biblScope unit="page" from="773" to="775" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Resolving postoperative neuroinflammation and cognitive decline</title>
		<author>
			<persName><forename type="first">N</forename><surname>Terrando</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">I</forename><surname>Eriksson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Ryu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Monaco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Feldmann</surname></persName>
		</author>
		<idno type="DOI">10.1002/ana.22664</idno>
		<idno type="PMID">22190370</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of neurology</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="986" to="995" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Lack of recovery in monocyte human leukocyte antigen-DR expression is independently associated with the development of sepsis after major trauma</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cheron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Floccard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Allaouchiche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guignant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Poitevin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Malcus</surname></persName>
		</author>
		<idno type="DOI">10.1186/cc9331</idno>
		<idno type="PMID">21092108</idno>
		<idno type="PMCID">PMC3220028</idno>
	</analytic>
	<monogr>
		<title level="m">R208. Epub</title>
				<imprint>
			<date type="published" when="2010">2010. 2010/11/26</date>
			<biblScope unit="volume">14</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Preventive antibacterial therapy in acute ischemic stroke: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Harms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Prass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Klehmet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Rogge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drenckhahn</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0002158</idno>
		<idno type="PMID">18478129</idno>
		<idno type="PMCID">PMC2373885</idno>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page">e2158</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">The use of Flt3 ligand as an adjuvant for hepatitis B vaccination of healthy adults</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">G</forename><surname>Evans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hasan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Galibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Caron</surname></persName>
		</author>
		<idno type="PMID">12450708</idno>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3-4</biblScope>
			<biblScope unit="page" from="322" to="329" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
